[125I]cetrorelix [7616]
[125I]cetrorelix
| SMILES | CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc([125I])cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O |
| InChIKey | MVDPNTCYCFVFOX-SZENRQNHSA-N |
| Sequence | AFASYXLRPA |
Chemical Properties
| Hydrogen bond acceptors | 16 |
| Hydrogen bond donors | 16 |
| Rotatable bonds | 38 |
| Log P | -0.765 |
| Molecular weight (Da) | 1519.6 |
| Stereochemistry info | unspecified |
| Radioactive | 125I |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
[125I]cetrorelix
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0